15 Jun 15

The PNAS study could explain why have efforts to TGF – beta activity only in T cells promote a limited impact in the treatment of autoimmune diseases, said Flavell.the authors speculated that the strengthening TGF – beta activity on dendritic cells could potentially have therapeutic effects in patients with MS and other autoimmune diseases.authors of the study include Yasmina Laouar, Terrence Town, David Jeng, Elise Tran, Yisong Wan and Vijay K. Kuchrooby the by the National Institutes of Health. Citation: PNAS 28th p between JDRF and Housey Pharmaceutical Research Laboratories To Further Diabetes ResearchThe Juvenile Diabetes Research Foundation, the world is largest charitable funder of type 1 diabetes research, a partnership with Housey Pharmaceutical Research Laboratories of the company studies support announced to identify compounds in order to promote the regeneration of the functional beta cells of the pancreas as a potential treatment for type 1 diabetes.

Autoimmune disease in which the. One person, the pancreas stops producing insulin, a hormone that people can get energy from food Type 1 diabetes usually strikes in childhood, adolescence or young adulthood, but for a lifetime. People with type 1 diabetes have multiple injections of insulin daily or continuous infusion of insulin through a pump just to survive. Type 2 diabetes is a metabolic disorder in which the body of a person still produces insulin, but not able Type 2 effectively. Type 2 is in adulthood in adulthood and does not always require. Under insulin insulin injections do not cure any type of diabetes nor that the possibility of subsequent and devastating.: Kidney failure, blindness, nerve damage, amputation, creation, attack and stroke..And minority interests , also throws questions whether or results of the study to generalize reliably the total population. ‘There are many possible causes that were identified for the fall in clinical trial participation,’said Hugh A. Sampson, Dean for Translational Biomedical Research at the Mount Sinai School of Medicine. ‘There is tremendous lack of public awareness on the importance of clinical trial. Patients also are often reluctant happened to randomly to a traditional or monitoring of treatment. Misunderstandings or mistrust towards the research is well a growing concern.

– Discuss how the academic medical centers able to establish successful community partnerships the public commitment public engagement in clinical trials. – Next a public debate, a comprehensive create strategy for a stronger involvement of the public in clinical trials.